Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group

Documenti analoghi

• Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
  di: Julie Voeller, et al.
  Pubblicazione: (2024)
• Enrollment on upfront high‐risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group
  di: Puja J. Umaretiya, et al.
  Pubblicazione: (2024)
• Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group
  di: Rebecca J. Deyell, et al.
  Pubblicazione: (2026)
• Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531
  di: Erin K. Barr, et al.
  Pubblicazione: (2024)
• A 2035 Clinical Research Vision and Roadmap for High‐Risk Neuroblastoma
  di: Lucas Moreno, et al.
  Pubblicazione: (2025)